Back

Metallo-protease Peptidase M84 from Bacillus altitudinis induces ROS dependent apoptosis in ovarian cancer cells by targeting PAR-1

Nag, N.; Ray, T.; Tapader, R.; Gope, A.; Das, R.; Mahapatra, E.; Saha, S.; Pal, A.; Prasad, P.; Chatterjee, S.; Roy, S. S.; Pal, A.

2023-09-06 cancer biology
10.1101/2023.09.06.556500 bioRxiv
Show abstract

In pursuit of isolating novel anticancer proteases from environmental microbial isolates, we have purified and identified an extracellular metallo-protease from Bacillus altitudinis named Peptidase M84. This protease selectively triggered apoptosis in human ovarian adenocarcinoma cells (PA-1, SKOV3) and mouse ovarian carcinoma cells (ID8), in addition to exhibiting no significant effect on normal human epithelial ovarian cell (IOSE) and mouse peritoneal macrophage (PEM[FE]) cell viabilities. Protease activated receptor-1 (PAR-1); a GPCR which is reported to be overexpressed in ovarian cancer cells was identified as a novel target of Peptidase M84. We observed that Peptidase M84 induced PAR-1 overexpression along with activating its downstream signalling effectors NF{kappa}B and MAPK to promote excessive reactive oxygen species (ROS) generation in ovarian cancer cells. This disrupted mitochondrial membrane potential, allowed cytosolic release of mitochondrial cytochrome c, increased the Bax (pro-apoptotic) to Bcl-2 (anti-apoptotic) ratio and promoted DNA damage to evoke apoptotic death of the ovarian cancer cells. Peptidase M84 also reduced nuclear ki-67 expression in these malignant cells to render an anti-proliferative role. In in vivo set-up, weekly intraperitoneal administration of Peptidase M84 (12 {micro}g/kg body-weight) in the ID8 mice model significantly diminished ascitic fluid accumulation through induction of oxidative stress, increasing murine survival rates by 60%. Collectively, our in vitro and in vivo findings suggested that Peptidase M84 triggered PAR-1 mediated oxidative stress to act as an apoptosis inducer in ovarian cancer cells. This established Peptidase M84 as a promising drug candidate for receptor mediated targeted-therapy of ovarian cancer. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=158 HEIGHT=200 SRC="FIGDIR/small/556500v2_ufig1.gif" ALT="Figure 1"> View larger version (51K): org.highwire.dtl.DTLVardef@6b0a19org.highwire.dtl.DTLVardef@1640510org.highwire.dtl.DTLVardef@1888b49org.highwire.dtl.DTLVardef@1708114_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 17 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 12%
6.5%
2
Pharmaceuticals
33 papers in training set
Top 0.1%
4.4%
3
Cell Death Discovery
51 papers in training set
Top 0.1%
4.2%
4
Cell Death & Disease
126 papers in training set
Top 0.2%
4.2%
5
Molecules
37 papers in training set
Top 0.1%
4.0%
6
Frontiers in Chemistry
14 papers in training set
Top 0.1%
3.7%
7
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.1%
3.6%
8
Cell Chemical Biology
81 papers in training set
Top 0.9%
2.9%
9
RSC Advances
18 papers in training set
Top 0.3%
2.4%
10
Redox Biology
64 papers in training set
Top 0.3%
2.4%
11
Journal of Medicinal Chemistry
68 papers in training set
Top 0.5%
2.1%
12
Chemistry – A European Journal
13 papers in training set
Top 0.2%
2.1%
13
Angewandte Chemie International Edition
81 papers in training set
Top 2%
1.9%
14
Advanced Science
249 papers in training set
Top 10%
1.8%
15
ACS Omega
90 papers in training set
Top 2%
1.7%
16
Scientific Reports
3102 papers in training set
Top 57%
1.7%
17
Environmental Research
46 papers in training set
Top 0.8%
1.7%
50% of probability mass above
18
ACS Chemical Biology
150 papers in training set
Top 1%
1.5%
19
iScience
1063 papers in training set
Top 17%
1.5%
20
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.8%
1.4%
21
International Journal of Biological Macromolecules
65 papers in training set
Top 2%
1.4%
22
Journal of Proteome Research
215 papers in training set
Top 2%
1.2%
23
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
24
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.7%
1.1%
25
PeerJ
261 papers in training set
Top 11%
1.0%
26
ChemMedChem
15 papers in training set
Top 0.4%
1.0%
27
Heliyon
146 papers in training set
Top 5%
0.9%
28
Journal of the American Chemical Society
199 papers in training set
Top 4%
0.9%
29
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.9%
30
Cell Reports
1338 papers in training set
Top 31%
0.8%